Hospital
Bradley County Medical Center
Bradley County Medical Center was paid $2.29M by Medicaid between Jan 2018 and Dec 2024, across 123 billing codes. Its largest line is 87502, Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets — 11% of everything it billed.
33Billing provider infoBRADLEY COUNTY MEDICAL CENTER
WARREN, AR 71671
WARREN, AR 71671
33aNPI1194741611assigned 07/15/2006
33bProvider typeCritical Access Hospital
28Total paid$2.29M
24GClaims118,168
24DCodes billed123
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Arkansas
Rank by total paid#6 of 34
Median peer was paid$773K
This provider vs. median3.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,913 | $248K | |
| 2019 | 19,717 | $440K | |
| 2020 | 19,004 | $350K | |
| 2021 | 20,700 | $352K | |
| 2022 | 16,159 | $365K | |
| 2023 | 14,482 | $337K | |
| 2024incomplete | 10,193 | $195K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 11% | 2,541 | 2,329 | $262K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 7.6% | 3,696 | 900 | $173K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 6.4% | 3,174 | 2,898 | $145K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.7% | 13,996 | 10,510 | $129K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.1% | 1,753 | 1,433 | $116K |
| 80053 | Comprehensive metabolic panel | 5.1% | 11,266 | 9,223 | $116K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.9% | 1,238 | 1,081 | $113K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.5% | 345 | 278 | $81K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.1% | 1,535 | 1,428 | $70K |
| 87634 | 2.7% | 781 | 736 | $62K | |
| 36415 | Collection of venous blood by venipuncture | 2.3% | 6,546 | 4,455 | $53K |
| 83880 | 2.3% | 1,979 | 1,616 | $52K |
111 more codes
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.2% | 1,084 | $49K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.1% | 1,078 | $49K |
| 99285 | Emergency room visit (most serious) | 1.8% | 1,380 | $42K |
| 71046 | Radiologic examination, chest; 2 views | 1.8% | 2,180 | $41K |
| 99284 | Emergency room visit (serious) | 1.6% | 933 | $37K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.6% | 3,701 | $36K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.6% | 835 | $36K |
| 71045 | Radiologic examination, chest; single view | 1.5% | 2,582 | $35K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.5% | 436 | $34K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.4% | 237 | $31K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.2% | 1,225 | $26K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 2,571 | $26K |
| 80050 | General health panel | 1.1% | 553 | $25K |
| 87070 | 1.1% | 2,356 | $25K | |
| 84484 | 1.0% | 2,280 | $23K | |
| 80061 | Lipid panel | <1% | 2,260 | $22K |
| 87088 | <1% | 2,984 | $21K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,531 | $20K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,474 | $19K |
| 81001 | <1% | 6,710 | $19K | |
| 82553 | <1% | 1,299 | $18K | |
| 82550 | <1% | 1,925 | $17K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 497 | $15K |
| 81025 | <1% | 1,783 | $15K | |
| 87077 | <1% | 2,030 | $13K | |
| 99283 | Emergency room visit (moderate) | <1% | 140 | $13K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,586 | $13K |
| 83735 | <1% | 1,931 | $12K | |
| 84439 | <1% | 1,436 | $11K | |
| 59025 | Fetal non-stress test | <1% | 59 | $9K |
| 87186 | <1% | 1,954 | $9K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 27 | $8K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 127 | $8K |
| 85610 | <1% | 2,199 | $7K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 170 | $7K |
| 86901 | <1% | 177 | $7K | |
| 84481 | <1% | 597 | $7K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 581 | $7K |
| 85730 | <1% | 1,159 | $6K | |
| 86900 | <1% | 181 | $6K | |
| 87040 | <1% | 515 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 128 | $5K |
| 83690 | <1% | 583 | $5K | |
| 85027 | <1% | 628 | $4K | |
| 80164 | <1% | 461 | $4K | |
| 97161 | <1% | 84 | $4K | |
| 82607 | <1% | 311 | $4K | |
| 83605 | <1% | 386 | $4K | |
| 82746 | <1% | 421 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 279 | $3K |
| 94760 | <1% | 216 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 30 | $3K |
| 71020 | <1% | 260 | $3K | |
| 86701 | <1% | 257 | $3K | |
| 82728 | <1% | 212 | $3K | |
| 87400 | <1% | 445 | $3K | |
| 82150 | <1% | 324 | $2K | |
| 85379 | <1% | 236 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 55 | $2K |
| 86703 | <1% | 99 | $2K | |
| 73630 | <1% | 73 | $2K | |
| 83540 | <1% | 209 | $1K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 35 | $1K |
| 80076 | <1% | 234 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 254 | $1K |
| 73564 | <1% | 30 | $1K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 12 | $1K |
| 86885 | <1% | 173 | $949.13 | |
| 82948 | <1% | 180 | $864.94 | |
| 82803 | <1% | 27 | $824.94 | |
| 83655 | <1% | 48 | $750.32 | |
| 74018 | <1% | 35 | $667.69 | |
| 82565 | <1% | 58 | $658.20 | |
| 86592 | <1% | 122 | $640.48 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 45 | $595.16 |
| 84550 | <1% | 108 | $557.60 | |
| 87210 | <1% | 103 | $543.54 | |
| 73130 | <1% | 17 | $496.84 | |
| 72110 | <1% | 15 | $481.89 | |
| 74022 | <1% | 12 | $471.12 | |
| 82248 | <1% | 115 | $460.85 | |
| 86677 | <1% | 36 | $451.24 | |
| 85652 | <1% | 162 | $443.54 | |
| 86328 | <1% | 75 | $432.89 | |
| 87076 | <1% | 59 | $425.69 | |
| 80320 | <1% | 33 | $398.03 | |
| 83550 | <1% | 28 | $350.83 | |
| 82570 | <1% | 69 | $347.77 | |
| 87280 | <1% | 33 | $347.49 | |
| 84520 | <1% | 45 | $295.71 | |
| 74019 | <1% | 19 | $281.34 | |
| 73610 | <1% | 13 | $248.39 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 13 | $208.00 |
| 84702 | <1% | 21 | $196.18 | |
| 82043 | <1% | 34 | $194.51 | |
| 80329 | <1% | 16 | $184.12 | |
| 71010 | <1% | 39 | $180.00 | |
| 87807 | <1% | 17 | $169.13 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 32 | $132.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 12 | $121.36 |
| 82950 | <1% | 13 | $74.58 | |
| 36416 | <1% | 120 | $61.71 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 125 | $58.31 |
| 82962 | <1% | 15 | $39.33 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 46 | $35.94 |
| 84450 | <1% | 28 | $29.52 | |
| 82947 | <1% | 12 | $22.40 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 28 | $4.18 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 35 | $0.04 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 32 | $0.04 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHUITT, LESLIE (CEO/CFO)
| Provider | Location | Paid |
|---|---|---|
| Bradley County Medical Center | Warren, AR | $542K |
| Bradley County Medical Center | Warren, AR | $146K |
| Bradley County Medical Center | Warren, AR | $2K |
| Bradley County Medical Center | Warren, AR | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.